Pharmafile Logo
Pharmafocus logo
Advanced Search

antipsychotic

Showing 5 posts of 5 posts found.

nursing_home

Behavioural intervention reduces need for antipsychotics in dementia treatment

April 19, 2017
Research and Development antipsychotic, dementia

A new study has suggested that dementia patients may not require as high a dosage of antipsychotic medication that was …

News
J&J image

J&J hit with $2.2 billion fine

November 5, 2013
Sales and Marketing J&J, JJ, Janssen, Risperdal, antipsychotic, fine

Johnson & Johnson has admitted promoting its big-selling antipsychotic drug Risperdal off-label, costing the firm $2.2 billion in fines. The …

News

Lilly hit by Zyprexa losses

January 30, 2013
Sales and Marketing antipsychotic, lilly, zyprexa

The loss of exclusivity on Eli Lilly’s blockbuster antipsychotic Zyprexa hit the company hard in 2012, with the firm’s overall …

News

AZ adds new heart warning to Seroquel

July 21, 2011
Sales and Marketing Seroquel, antipsychotic

AstraZeneca has added a new heart warning to the packaging on its antipsychotic drug Seroquel at the behest of the …

News

Janssen’s monthly antipsychotic approved in Europe

March 9, 2011
Sales and Marketing Janssen, Xeplion, antipsychotic, injectible antipsychotic, paliperidone palmitate, schizophrenia

Janssen’s injectable antipsychotic Xeplion has been approved by the European Commission for the treatment of schizophrenia. There is no cure …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025